Do you think I would even take investment advice from a

New Post Public Reply Private Reply Replies (1) Message Board
Goosebumps Steel Reserve #96072
278
Do you think I would even take investment advice from a right wing nut like you or even worse Trump? That’s hilarious. For your information… Trumps advice would of bankrupted me or you. He has lost money every year if you are gullible enough to believe his newly released taxes.

Trump the business man that shows losses for the last 10 years… now that his taxes are an open book. We can all see that he isn’t who he says he is. But the people that recognized this already have known this all along. Once a loser like Trump always a loser. Now we have the proof of just how much of a loser he is with his taxes not being properly paid and using fake loop holes that the government doesn’t even know or allow. Or is he just lying to not pay taxes? Well… It’s lying and this is how things turn out when you try for years not to show your taxes to the people ( like every president has done) of this country and lie about a ongoing IRS review/audit that was never happening to even lie about not being able to reveal his taxes because of this. What a standing joke he played on his followers. Did you believe in a 6 year Audit? We’re you that gullible? Didn’t you ever wonder why he couldn’t or wouldn’t reveal his taxes? We’re you never suspect of a shister like this. Bought any snake oil lately?

Of coarse most of us know that Trump is the king of daily lies and never stops lying. Fact checked to have over 20,000 lies in his 4 years as president. Hmmm… somebody knew he was a liar.

I often wondered if it was how he was raised but I think his ability to lie is something he grew up with. Being a silver spoon liar from birth is more reasonable to believe. A person can’t lie as much as Trump does and not have this be a learned behavior from a young age.

It’s the people like you and your right wing nuts that buy his lies… hook… line… and sinker… swallowing it all. Believing everything Trump says… only a idiot would believe his lies. Is that you Steel Reserve? Or your other far right wing nut buddies on here. How gullible are you people.

A good judge of character can easily see a liar. You wing nuts prove you can’t see a liar when he lies straight up almost everything he says is an exaggeration or lie. Mostly out right lies.

If you haven’t figured this out about me yet… I hate a liar. There is nothing worse than a wannabe leader that lives on lies. I want to depend on a leader to lead with truths. To be able to trust a leader is everything.

I am not a fool and believe that politicians don’t lie. But when one lie leads to a non stop lying train of never ending lies like Trump has proven to be. You just can’t trust Trump or anyone like him. But you idiots that can’t see the lies… amaze me. I didn’t believe that people this day in age can be so gullible.

The rich owning the media as they do… can convince the less intelligent public of anything. Is this you Steel Reserve? Do you only read and watch right wing media? Is it smart to put all your proverbial news eggs in one basket? To be truly informed you have to listen to both sides of the media. We all know there are two sides to the media. Being able to watch and or read both only gives most of us the ability to make informed decisions. Not the far left people or the far right people though. They don’t mix their news and believe a warped one sided view like you and your far right buddies on here that are pretty clueless.
3
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 234

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
TCL Tablets Arrive on BestBuy.com: What It Means

Updated Category News Views 11

Go Big or Go Home: TCL's Bold Move TCL just dropped a little bombshell that's gonna ripple through the electronics retail market—its tablets and smartphones are now bright and shiny on BestBuy.com. It's like standing at the craps table and before you know it, the stakes have just doubled. Why? Best Buy ain't some hole-in-the-wall spot. It's the premium electronics...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 345

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Formation Unveils First Solana Tokenized Securities Venue

Updated Category News Views 22

Well, here we go. Formation Securities is setting sail on the high seas of blockchain, aiming to operate a tokenized securities venue (TSV) on Solana. This isn't your garden-variety launch—it's a bold leap into a newer, faster-paced world of trading. Sure, you’ve heard about blockchains before, but this operation marries the traditional rigmarole of the stock market...

Continue Reading
Continuous Insulation Market Grows, Hits $67.74B by 2031

Updated Category News Views 19

Market Trends and Key Drivers Imagine riding a slow but steady bull market in insulation—sounds mundane, but the numbers don't lie. MarketsandMarkets™ had the scoop, predicting the Continuous Insulation Market will balloon from USD 56.98 billion in 2026 to USD 67.74 billion by 2031, putting down roots with a 3.5% CAGR. Now, you and I both know that when real estate...

Continue Reading
Tigo Energy Faces Class Action: Investor Deadline Looms

Updated Category News Views 5

Unpacking Tigo's Rollercoaster: Lawsuit & Market Reaction They sometimes say, "When it rains, it pours." For Tigo Energy, it’s been more a downpour than a drizzle. Here we are, chasing down what's going on with Tigo Energy (NASDAQ:TYGO), fresh off the heels of a class action fuss that's grabbed every investor's attention. If you've got a stake, or even a passing...

Continue Reading
O-I Glass Faces Class Action: Investor Implications

Updated Category News Views 130

O-I Glass in Hot Water Over Misleading Statements I'll tell you, nothing gets my goat quite like uncovering deceptive practices in the corporate world. It seems O-I Glass, Inc. (NYSE: OI), might have played a fast one with its shareholders. The company is staring down the barrel of a class action lawsuit from Schall, Brown & Schwartz LLP, alleging they weren't entirely...

Continue Reading
Photocure Navigates AssureMDx's Medicare Journey

Updated Category News Views 99

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

Continue Reading
AWS Boosts Agilix's AI Education in Sierra Leone

Updated Category News Views 99

Agilix Labs' Landmark Leap with AWS Just when you think you've got the grip on global education dynamics, a new wave hits your shores, this time courtesy of Agilix Labs and AWS. Agilix Labs snagged a grant from Amazon Web Services, carving a path that blends AI with educational equity in Sierra Leone. Now, if that doesn’t prick up investor ears or yank a few...

Continue Reading
Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Updated Category News Views 7

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...

Continue Reading

Top 5 Most Recently Viewed Articles

Captain D's Expands Globally with New Franchise Agreement

Updated Category News Views 653

Captain D's Takes a Giant Leap into Global Expansion In a significant move for its global growth strategy, Captain D's, the leading fast-casual seafood restaurant in the nation, has signed a major franchise agreement aimed at establishing its brand in the UK. This new venture marks a noteworthy milestone as the company prepares to serve its renowned seafood offerings to a...

Continue Reading
Understanding Your Rights as an Alto Neuroscience Shareholder

Updated Category News Views 129

Understanding Your Rights as an Alto Neuroscience Shareholder Alto Neuroscience, Inc. (NASDAQ: ANRO) has recently been in the spotlight as shareholder rights issues arise. For those investors who acquired shares, it is important to understand the implications of these developments and the actions that may be available to you. Why Should Shareholders Take Action? As a...

Continue Reading
Taiwan Fund, Inc. Shares Key Stockholder Meeting Outcomes

Updated Category News Views 170

The Taiwan Fund, Inc. Announces Stockholders Meeting Results The Taiwan Fund, Inc. (TWN), a prominent closed-end investment entity, recently revealed the outcomes of its Annual Stockholders Meeting. This important event, focusing on the future direction of the Fund, showcased a solid commitment from investors as they participated in key voting processes. Board of...

Continue Reading
Canadian Solar Inc. Delivers Solid Q2 2025 Financial Results

Updated Category News Views 295

Strong Performance by Canadian Solar Canadian Solar Inc. (NASDAQ: CSIQ) has recently reported its impressive financial results for the second quarter. The highlights include an increase in solar module shipments, reflecting the company's ongoing advancement in the renewable energy sector. Second Quarter Highlights The second quarter showcased a 14% quarter-over-quarter...

Continue Reading
Otto Aviation Partners with Galorath for Enhanced Cost Estimation

Updated Category News Views 219

Otto Aviation Partners with Galorath for Enhanced Estimation In a groundbreaking move, Otto Aviation has made a strategic decision to standardize its operations on Galorath's AI-powered estimation platform. This collaboration is set to significantly enhance Otto's pricing strategies as it ventures into sustainable aerospace projects, aiming to revolutionize the future of...

Continue Reading